Management of C-difficile Infection (CDI)

This podcast addresses the complexities of Clostridioides difficile infection (CDI), commonly known as C-diff, particularly its severe and fulminant manifestations in the ICU. Dr. Max Adelman, an infectious disease specialist from Emory University, joins the host to discuss the epidemiology, risk factors, diagnosis, and management of C-diff. C-diff is highlighted as the most common hospital-acquired infection, with antibiotic use, especially cephalosporins, identified as a major modifiable risk factor. Diagnostic strategies involve a two-step process of detecting the presence of C-diff and then testing for toxin production. Treatment approaches range from oral vancomycin and IV metronidazole to fecal microbiota transplants (FMT) and surgical interventions like colectomies for severe cases. The discussion emphasizes early involvement of surgeons in critical cases and the importance of infection control measures to prevent outbreaks.